Patent Assignment
Reel/Frame 052794/0116
Confirmatory License
Recorded: 2020-05-29
Pages: 2
Assignor
BOSTON CHILDREN'S HOSPITAL
Executed: 2020-05-26
Assignee
NIH-DEITR
6705 ROCKLEDGE DRIVE, BETHESDA, MARYLAND, 20892-7974
Covered Property
(1)
Inhibition of Neovasuclarization Using Vegf-Specific Oligonucleotides
Patent:
5,731,294 →
Application:
08/378,860 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 27, 1995
From: ROBINSON, GREGORY S.
To: HYBRIDON, INC.
Reel/Frame 007455/0492 →
Assignment of Assignor's Interest
Apr 27, 1995
From: SMITH, LOIS ELAINE HODGSON
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 007455/0498 →
Security Interest
Jan 29, 1998
From: HYBRIDON, INC.
To: SILICON VALLEY BANK
Reel/Frame 008933/0844 →
Merger and Change of Name
Nov 30, 2005
From: HYBRIDON, INC
To: IDERA PHARMACEUTICALS, INC
Reel/Frame 017240/0865 →
Confirmatory License
Jun 17, 2009
From: CHILDREN'S HOSPITAL (BOSTON)
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022839/0409 →